Preapproval and postapproval evidence on drugs for multiple sclerosis
Sign Up to like & getrecommendations! Published in 2018 at "Neurology"
DOI: 10.1212/wnl.0000000000005561
Abstract: Objective To review the evidence supporting the European Union marketing authorization of drugs for multiple sclerosis (MS) and assess how far postmarketing research addresses information gaps at the time of approval. Methods Through its database,… read more here.
Keywords: evidence; multiple sclerosis; postapproval evidence; preapproval postapproval ... See more keywords